nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicoumarol—GPR35—central nervous system—malignant glioma	0.0726	0.12	CbGeAlD
Dicoumarol—VKORC1—blood vessel—malignant glioma	0.0676	0.111	CbGeAlD
Dicoumarol—CRYZ—embryo—malignant glioma	0.0585	0.0964	CbGeAlD
Dicoumarol—GPR35—brain—malignant glioma	0.0577	0.095	CbGeAlD
Dicoumarol—CRYZ—medulla oblongata—malignant glioma	0.0374	0.0616	CbGeAlD
Dicoumarol—CRYZ—midbrain—malignant glioma	0.0342	0.0563	CbGeAlD
Dicoumarol—CRYZ—spinal cord—malignant glioma	0.0334	0.0549	CbGeAlD
Dicoumarol—CRYZ—central nervous system—malignant glioma	0.0271	0.0446	CbGeAlD
Dicoumarol—CRYZ—cerebellum—malignant glioma	0.0264	0.0436	CbGeAlD
Dicoumarol—VKORC1—Gamma-carboxylation, transport, and amino-terminal cleavage of proteins—F2—malignant glioma	0.0248	0.0653	CbGpPWpGaD
Dicoumarol—NQO1—retina—malignant glioma	0.0221	0.0364	CbGeAlD
Dicoumarol—CRYZ—brain—malignant glioma	0.0215	0.0354	CbGeAlD
Dicoumarol—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—COX8A—malignant glioma	0.0215	0.0566	CbGpPWpGaD
Dicoumarol—NQO1—telencephalon—malignant glioma	0.0203	0.0335	CbGeAlD
Dicoumarol—VKORC1—central nervous system—malignant glioma	0.0186	0.0307	CbGeAlD
Dicoumarol—VKORC1—cerebellum—malignant glioma	0.0182	0.03	CbGeAlD
Dicoumarol—NQO1—Dopamine metabolism—SOD1—malignant glioma	0.0179	0.0472	CbGpPWpGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—CCR4—malignant glioma	0.0177	0.0467	CbGpPWpGaD
Dicoumarol—NQO1—medulla oblongata—malignant glioma	0.016	0.0263	CbGeAlD
Dicoumarol—VKORC1—brain—malignant glioma	0.0148	0.0244	CbGeAlD
Dicoumarol—NQO1—midbrain—malignant glioma	0.0146	0.024	CbGeAlD
Dicoumarol—NQO1—spinal cord—malignant glioma	0.0142	0.0234	CbGeAlD
Dicoumarol—Warfarin—CYP2C18—malignant glioma	0.0139	1	CrCbGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—CXCR3—malignant glioma	0.0132	0.0347	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.0127	0.0335	CbGpPWpGaD
Dicoumarol—GPR35—GPCRs, Class A Rhodopsin-like—BDKRB2—malignant glioma	0.012	0.0317	CbGpPWpGaD
Dicoumarol—VKORC1—PTM: gamma carboxylation, hypusine formation and arylsulfatase activation—F2—malignant glioma	0.0117	0.0309	CbGpPWpGaD
Dicoumarol—NQO1—central nervous system—malignant glioma	0.0115	0.019	CbGeAlD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.0113	0.0299	CbGpPWpGaD
Dicoumarol—NQO1—cerebellum—malignant glioma	0.0113	0.0186	CbGeAlD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—PLK1—malignant glioma	0.00977	0.0258	CbGpPWpGaD
Dicoumarol—NQO1—brain—malignant glioma	0.00917	0.0151	CbGeAlD
Dicoumarol—NQO1—Oxidative Stress—SOD1—malignant glioma	0.00916	0.0242	CbGpPWpGaD
Dicoumarol—CYP2C9—CYP2E1 reactions—CYP2B6—malignant glioma	0.00906	0.0239	CbGpPWpGaD
Dicoumarol—NQO1—Oxidative Stress—CAT—malignant glioma	0.0087	0.0229	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—PML—malignant glioma	0.00825	0.0218	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.00798	0.021	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—FTH1—malignant glioma	0.00783	0.0206	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—JAG1—malignant glioma	0.00705	0.0186	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—POR—malignant glioma	0.00661	0.0174	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—malignant glioma	0.00632	0.0167	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—ASMT—malignant glioma	0.00594	0.0157	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.00587	0.0155	CbGpPWpGaD
Dicoumarol—CYP2C9—Xenobiotics—CYP2B6—malignant glioma	0.00561	0.0148	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—PTK2—malignant glioma	0.00533	0.0141	CbGpPWpGaD
Dicoumarol—NQO1—Transcriptional activation by NRF2—PIK3CA—malignant glioma	0.00496	0.0131	CbGpPWpGaD
Dicoumarol—CYP2C9—Xenobiotics—CYP2C18—malignant glioma	0.00487	0.0128	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—BIRC5—malignant glioma	0.00474	0.0125	CbGpPWpGaD
Dicoumarol—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00386	0.0102	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00367	0.00969	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	0.00343	0.00905	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	0.0034	0.00897	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	0.00329	0.00868	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—XBP1—malignant glioma	0.00314	0.00827	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—SLC5A5—malignant glioma	0.00313	0.00825	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN2A—malignant glioma	0.00309	0.00816	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	0.00306	0.00807	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	0.00305	0.00804	CbGpPWpGaD
Dicoumarol—NQO1—Validated transcriptional targets of TAp63 isoforms—MDM2—malignant glioma	0.003	0.00792	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—SLC6A3—malignant glioma	0.00298	0.00786	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	0.00259	0.00683	CbGpPWpGaD
Dicoumarol—NQO1—Amino acid and derivative metabolism—SLC5A5—malignant glioma	0.00256	0.00674	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—GSTP1—malignant glioma	0.00252	0.00665	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—MYC—malignant glioma	0.00238	0.00629	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	0.00233	0.00615	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	0.00233	0.00615	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.00233	0.00615	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—SPHK1—malignant glioma	0.00233	0.00613	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.0023	0.00607	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—RTEL1—malignant glioma	0.00223	0.0059	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	0.00222	0.00586	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—TNF—malignant glioma	0.00222	0.00586	CbGpPWpGaD
Dicoumarol—NQO1—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	0.0022	0.00581	CbGpPWpGaD
Dicoumarol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.00202	0.00533	CbGpPWpGaD
Dicoumarol—CYP2C9—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00199	0.00526	CbGpPWpGaD
Dicoumarol—NQO1—NRF2 pathway—PDGFB—malignant glioma	0.00199	0.00526	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—malignant glioma	0.00198	0.00523	CbGpPWpGaD
Dicoumarol—VKORC1—Post-translational protein modification—F2—malignant glioma	0.00192	0.00506	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.00189	0.00499	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—PTGS1—malignant glioma	0.00177	0.00468	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00164	0.00432	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—BCHE—malignant glioma	0.0016	0.00423	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—FBXW7—malignant glioma	0.00158	0.00417	CbGpPWpGaD
Dicoumarol—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—AKT1—malignant glioma	0.00148	0.00389	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—COX8A—malignant glioma	0.00128	0.00339	CbGpPWpGaD
Dicoumarol—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.00124	0.00328	CbGpPWpGaD
Dicoumarol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00118	0.0031	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—ASMT—malignant glioma	0.00109	0.00288	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—BCAN—malignant glioma	0.00103	0.00271	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP2B6—malignant glioma	0.001	0.00265	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—CYP2B6—malignant glioma	0.00099	0.00261	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—F2—malignant glioma	0.00091	0.0024	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—CYP2C18—malignant glioma	0.00087	0.0023	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—CYP2C18—malignant glioma	0.000859	0.00226	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—IDH2—malignant glioma	0.000827	0.00218	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP2B6—malignant glioma	0.000778	0.00205	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—MMP2—malignant glioma	0.000772	0.00204	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—IDH1—malignant glioma	0.000711	0.00188	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTT1—malignant glioma	0.000704	0.00186	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SPHK1—malignant glioma	0.000688	0.00182	CbGpPWpGaD
Dicoumarol—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	0.000679	0.00179	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CYP2C18—malignant glioma	0.000674	0.00178	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—PTGS1—malignant glioma	0.00066	0.00174	CbGpPWpGaD
Dicoumarol—VKORC1—Metabolism of proteins—CXCL8—malignant glioma	0.000642	0.00169	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTT1—malignant glioma	0.000545	0.00144	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PTGS1—malignant glioma	0.000511	0.00135	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—RTEL1—malignant glioma	0.000493	0.0013	CbGpPWpGaD
Dicoumarol—CYP2C9—Biological oxidations—GSTP1—malignant glioma	0.000488	0.00129	CbGpPWpGaD
Dicoumarol—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	0.000481	0.00127	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—BCHE—malignant glioma	0.000475	0.00125	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—SLC5A5—malignant glioma	0.000469	0.00124	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—GSTP1—malignant glioma	0.000378	0.000997	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CAT—malignant glioma	0.000368	0.00097	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000353	0.00093	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—NCOR1—malignant glioma	0.000347	0.000916	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000341	0.0009	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—COX8A—malignant glioma	0.000283	0.000748	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—CAV1—malignant glioma	0.000283	0.000747	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PIK3CG—malignant glioma	0.000258	0.00068	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000253	0.000668	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PPARG—malignant glioma	0.000249	0.000657	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—ASMT—malignant glioma	0.000241	0.000636	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000236	0.000621	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PIK3CD—malignant glioma	0.000227	0.000598	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—BCAN—malignant glioma	0.000227	0.000598	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PIK3CB—malignant glioma	0.000198	0.000521	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PTGS2—malignant glioma	0.000196	0.000517	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—IDH2—malignant glioma	0.000183	0.000482	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000172	0.000454	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP2B6—malignant glioma	0.000172	0.000453	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PTEN—malignant glioma	0.000171	0.000451	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—IDH1—malignant glioma	0.000157	0.000414	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SPHK1—malignant glioma	0.000152	0.000401	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CYP2C18—malignant glioma	0.000149	0.000393	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.00014	0.00037	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000128	0.000337	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000123	0.000326	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—PIK3CA—malignant glioma	0.00012	0.000318	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTT1—malignant glioma	0.00012	0.000318	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PTGS1—malignant glioma	0.000113	0.000298	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000112	0.000297	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—BCHE—malignant glioma	0.000105	0.000277	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—SLC5A5—malignant glioma	0.000104	0.000273	CbGpPWpGaD
Dicoumarol—NQO1—Metabolism—AKT1—malignant glioma	9.84e-05	0.00026	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	9.8e-05	0.000258	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	9.71e-05	0.000256	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	8.47e-05	0.000223	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—GSTP1—malignant glioma	8.35e-05	0.00022	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CAT—malignant glioma	8.12e-05	0.000214	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—NCOR1—malignant glioma	7.67e-05	0.000202	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—CAV1—malignant glioma	6.25e-05	0.000165	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.97e-05	0.000158	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PIK3CG—malignant glioma	5.69e-05	0.00015	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PPARG—malignant glioma	5.5e-05	0.000145	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.01e-05	0.000132	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.36e-05	0.000115	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PTGS2—malignant glioma	4.32e-05	0.000114	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PTEN—malignant glioma	3.77e-05	9.95e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.66e-05	7.02e-05	CbGpPWpGaD
Dicoumarol—CYP2C9—Metabolism—AKT1—malignant glioma	2.17e-05	5.73e-05	CbGpPWpGaD
